ZEVOTEK, INC. Inactive Instrument
Zevotek, Inc. Share Price Other OTC
Equities
ZVTK
US98953B3042
Investment Management & Fund Operators
| Sales 2011 | 15.54K 1.3M | Sales 2012 | 8.02K 670K | Capitalization | 38.26K 3.19M |
|---|---|---|---|---|---|
| Net income 2011 | -1M -83.44M | Net income 2012 | -1M -83.44M | EV / Sales 2011 | 55.2 x |
| Net Debt 2011 | 435K 36.29M | Net Debt 2012 | 1.53M 128M | EV / Sales 2012 | 196 x |
| P/E ratio 2011 |
-0.19
x | P/E ratio 2012 |
-0.02
x | Employees | - |
| Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 3.72% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Jeffrey Carlson
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeffrey Carlson
CEO | Chief Executive Officer | - | - |
Zevotek, Inc. is engaged in investing in startups and provides funding, development, suppliers and vendor management, software development, marketing, management, and research and development to its potential clients. The Company seeks to catalyze the business on the Internet of things (IOT), business automation, data processing, business analytics and connected healthcare sectors. The Company, through QT Medical, is focused on distributing medical devices.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.03% | 113B | |
| +20.42% | 63.85B | |
| +5.29% | 61.9B | |
| +10.12% | 42.86B | |
| +7.95% | 40.84B | |
| +18.88% | 34.58B | |
| +5.88% | 25.46B | |
| -5.25% | 22.13B | |
| +0.57% | 18.61B |
